NeuroTrax Invites APA Meeting Attendees to Help Create Insight, the Worlds First Online, Crowd-Sourced Cognitive Testing Service
San Francisco, Calif. (PRWEB) May 19, 2013
Reliable and practical office-based measurement of cognitive function has become critical for healthcare and disease management programs involving psychiatric and neurological disease. NeuroTrax Corporation, a pioneer in web-based cognitive assessment since 2000, is creating a next-generation service to help healthcare practitioners and organizations to more quickly and accurately assess cognitive status.
From its booth (#847) at the Annual Meeting of the American Psychiatric Association this week in San Francisco, NeuroTrax will be conducting a specialized survey to tap-in to the impressive “brain power” and experience of the more than 13,000 psychiatrists, neurologists and other professionals expected to attend the event from all over the world.
Using results from the survey, along with a strong scientific foundation of 70 peer-reviewed articles developed over years for its popular MindStreams service (http://www.neurotrax.com), NeuroTrax will complete the development of Insight™, a suite of services for evaluation of conditions ranging from memory complaints common to the elderly, to adolescent/adult attention issues.
Planned for international release later this year, Insight will be the world’s first online cognitive testing service to provide professional data review reports from trained cognitive testing experts.
Insight is designed to deliver accurate, valid cognitive functioning assessments, providing a comprehensive brain health report across multiple cognitive domains. Administered in a medical office setting with only minimal supervision required, the test is designed for patients of a wide age range, with or without prior computer experience. Test results, along with a professional report from a cognitive expert, are expediently generated by the service.
“Over the years, we have seen an increased awareness of the importance of obtaining a clear snapshot of the patient’s cognitive status as an important extension of the neurological examination. However, too many patients with complaints of poor memory or difficulty concentrating do not have access to quality testing,” said Ely Simon, M.D., a board certified neurologist and creator of Insight. “By combing the results from our survey, new technology, and a body of science and research developed over many years, we aim to create a new generation of readily accessible cognitive testing and expert reporting, which will benefit practitioners and their patients.”
ABOUT NEUROTRAX
NeuroTrax Corporation was founded in 2000, driven by the vision of elevating the standard of patient care. The company delivers quality cognitive testing products and services to the medical community. With careful attention to cutting edge technology and critical scientific studies, NeuroTrax has succeeded in leading the way in this growing field. To learn more, please visit us online at http://www.neurotrax.com.
